Evidence map›Paper›PMID 38067348›Full record

ArticleCancers2023

Efficient Radial-Shell Model for 3D Tumor Spheroid Dynamics with Radiotherapy.

Florian Franke, Soňa Michlíková, Sebastian Aland, Leoni A Kunz-Schughart, Anja Voss-Böhme, Steffen Lange

Abstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Tumor organoids modeling reveals timed responses and interplay of radiotherapy and chemotherapy in pancreatic cancer.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Florian FrankeDataMedAssist Group, HTW Dresden-University of Applied Sciences, 01069 Dresden, Germany.ORCID 0000-0002-0755-9451
Soňa MichlíkováOncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, 01307 Dresden, Germany.ORCID 0000-0002-1658-4632
Sebastian AlandFaculty of Informatics/Mathematics, HTW Dresden-University of Applied Sciences, 01069 Dresden, Germany.ORCID 0000-0002-5258-0006
Leoni A Kunz-SchughartOncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, 01307 Dresden, Germany.ORCID 0000-0003-3912-6594
Anja Voss-BöhmeDataMedAssist Group, HTW Dresden-University of Applied Sciences, 01069 Dresden, Germany.ORCID 0000-0001-6510-8694
Steffen LangeDataMedAssist Group, HTW Dresden-University of Applied Sciences, 01069 Dresden, Germany.ORCID 0000-0002-0511-8011

Funding

Bundesministerium für Bildung und Forschung BMBF 16dkwn001a/bDFG AL1705/11Open Access Publication Fund of Hochschule für Technik und Wirtschaft Dresden - University of Applied Sciences and by Deutsche Forschungsgemeinschaft 491382348Sächsisches Staatsministerium für Wissenschaft und Kunst (SMWK) FORZUG II TP 3the EU, the European Social Fund (ESF) and by tax funds on the basis of the budget passed by the Saxon state parliament 100382145
6 · The paper itself

Abstract

Understanding the complex dynamics of tumor growth to develop more efficient therapeutic strategies is one of the most challenging problems in biomedicine. Three-dimensional (3D) tumor spheroids, reflecting avascular microregions within a tumor, are an advanced in vitro model system to assess the curative effect of combinatorial radio(chemo)therapy. Tumor spheroids exhibit particular crucial pathophysiological characteristics such as a radial oxygen gradient that critically affect the sensitivity of the malignant cell population to treatment. However, spheroid experiments remain laborious, and determining long-term radio(chemo)therapy outcomes is challenging. Mathematical models of spheroid dynamics have the potential to enhance the informative value of experimental data, and can support study design; however, they typically face one of two limitations: while non-spatial models are computationally cheap, they lack the spatial resolution to predict oxygen-dependent radioresponse, whereas models that describe spatial cell dynamics are computationally expensive and often heavily parameterized, impeding the required calibration to experimental data. Here, we present an effectively one-dimensional mathematical model based on the cell dynamics within and across radial spheres which fully incorporates the 3D dynamics of tumor spheroids by exploiting their approximate rotational symmetry. We demonstrate that this radial-shell (RS) model reproduces experimental spheroid growth curves of several cell lines with and without radiotherapy, showing equal or better performance than published models such as 3D agent-based models. Notably, the RS model is sufficiently efficient to enable multi-parametric optimization within previously reported and/or physiologically reasonable ranges based on experimental data. Analysis of the model reveals that the characteristic change of dynamics observed in experiments at small spheroid volume originates from the spatial scale of cell interactions. Based on the calibrated parameters, we predict the spheroid volumes at which this behavior should be observable. Finally, we demonstrate how the generic parameterization of the model allows direct parameter transfer to 3D agent-based models.

Indexed as

3D growthcellular automatongrowth curveminimal modelradial shell modelradiation therapysimulationspatio-temporal mathematical modellingspheroidssystems biologytumor relapse

Identifiers

PMID38067348
PMCPMC10705470

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.